RST - DLMP Grand Rounds: From Allelic Susceptibility to Epigenomic Remodeling for Multiple Myeloma, December 3, 2025

Presenter: Linda Baughn, Ph.D.

Learning Objectives - Upon completion of this activity, participants should be able to:

• Explain how cyclin D1 regulates transcriptional programs and chromatin accessibility in addition to its canonical role in cell cycle control.
• Describe the genomic and molecular features associated with sensitivity and resistance to venetoclax in t(11;14) multiple myeloma.
• Identify therapeutic vulnerabilities and biological pathways emerging from cyclin D1–mediated transcriptional and metabolic reprogramming in t(11;14) multiple myeloma.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.